Literature DB >> 8270871

NADPH-binding component of the respiratory burst oxidase system: studies using neutrophil membranes from patients with chronic granulomatous disease lacking the beta-subunit of cytochrome b558.

S Tsunawaki1, H Mizunari, H Namiki, T Kuratsuji.   

Abstract

The NADPH-binding site of the respiratory burst oxidase system of neutrophils has been proposed to be either at a cytosolic component or at the beta-subunit of cytochrome b558. In this study, affinity labeling of resting and stimulated membranes, the latter having been assembled by all of the oxidase components from both membrane and cytosol, was carried out using [32P]NADPH dialdehyde (oNADPH). Stimulation of human neutrophils with PMA greatly increased O2(-)-generating activity and caused considerable translocation of the cytosolic components p47phox and p67phox. Nevertheless, PMA stimulation did not produce a labeled band which included positions at 47, 67, and approximately 32 kD. The most intense band reflected a molecular mass of 84 kD regardless of the state of activation, but a labeled band was never found near the beta-subunit (91 kD) of cytochrome b558. This 84-kD protein was further confirmed in neutrophils of 14 patients with gp91phox-deficient X-linked chronic granulomatous disease. These results indicate that the NADPH-binding component is not recruited from the cytosol, and also, that a membranous redox component besides cytochrome b558 must be involved in the NADPH oxidase system.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8270871      PMCID: PMC2191315          DOI: 10.1084/jem.179.1.291

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  29 in total

1.  Affinity labeling of the cytosolic and membrane components of the respiratory burst oxidase by the 2',3'-dialdehyde derivative of NADPH. Evidence for a cytosolic location of the nucleotide-binding site in the resting cell.

Authors:  R M Smith; J T Curnutte; B M Babior
Journal:  J Biol Chem       Date:  1989-02-05       Impact factor: 5.157

2.  Complete amino acid sequence of NADPH-cytochrome P-450 reductase from porcine hepatic microsomes.

Authors:  M Haniu; T Iyanagi; P Miller; T D Lee; J E Shively
Journal:  Biochemistry       Date:  1986-12-02       Impact factor: 3.162

3.  Modification of glucose-6-phosphate dehydrogenase from Leuconostoc mesenteroides with the 2',3'-dialdehyde derivative of NADP+ (oNADP+).

Authors:  B J White; H R Levy
Journal:  J Biol Chem       Date:  1987-01-25       Impact factor: 5.157

4.  Respiratory burst oxidase from human neutrophils: purification and some properties.

Authors:  M Markert; G A Glass; B M Babior
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

5.  Production of recombinant cytochrome b558 allows reconstitution of the phagocyte NADPH oxidase solely from recombinant proteins.

Authors:  D Rotrosen; C L Yeung; J P Katkin
Journal:  J Biol Chem       Date:  1993-07-05       Impact factor: 5.157

6.  The enzymic reduction and kinetics of oxidation of cytochrome b-245 of neutrophils.

Authors:  A R Cross; F K Higson; O T Jones; A M Harper; A W Segal
Journal:  Biochem J       Date:  1982-05-15       Impact factor: 3.857

7.  NADPH binding component of neutrophil superoxide-generating oxidase.

Authors:  T Umei; K Takeshige; S Minakami
Journal:  J Biol Chem       Date:  1986-04-25       Impact factor: 5.157

8.  Effect of 2',3'-dialdehyde NADPH on activation of superoxide-producing NADPH oxidase in a cell-free system of pig neutrophils.

Authors:  S Takasugi; K Ishida; K Takeshige; S Minakami
Journal:  J Biochem       Date:  1989-02       Impact factor: 3.387

9.  The respiratory burst oxidase of neutrophils. Separation of an FAD enzyme and its characterization.

Authors:  K Kakinuma; Y Fukuhara; M Kaneda
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

10.  Purification and characterization of NADPH-cytochrome c reductase from porcine polymorphonuclear leukocytes.

Authors:  H Kojima; K Takahashi; F Sakane; J Koyama
Journal:  J Biochem       Date:  1987-11       Impact factor: 3.387

View more
  7 in total

1.  Fungal metabolite gliotoxin targets flavocytochrome b558 in the activation of the human neutrophil NADPH oxidase.

Authors:  Satoshi Nishida; Lucia S Yoshida; Takashi Shimoyama; Hiroyuki Nunoi; Toshihiro Kobayashi; Shohko Tsunawaki
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

2.  The cytosolic subunit p67phox contains an NADPH-binding site that participates in catalysis by the leukocyte NADPH oxidase.

Authors:  R M Smith; J A Connor; L M Chen; B M Babior
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

3.  Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase.

Authors:  Shohko Tsunawaki; Lucia S Yoshida; Satoshi Nishida; Toshihiro Kobayashi; Takashi Shimoyama
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  Involvement of p40phox in activation of phagocyte NADPH oxidase through association of its carboxyl-terminal, but not its amino-terminal, with p67phox.

Authors:  S Tsunawaki; S Kagara; K Yoshikawa; L S Yoshida; T Kuratsuji; H Namiki
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

Review 5.  SH3-dependent assembly of the phagocyte NADPH oxidase.

Authors:  L C McPhail
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

6.  The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosis.

Authors:  Chang-Il Suh; Natalie D Stull; Xing Jun Li; Wei Tian; Marianne O Price; Sergio Grinstein; Michael B Yaffe; Simon Atkinson; Mary C Dinauer
Journal:  J Exp Med       Date:  2006-07-31       Impact factor: 14.307

Review 7.  Functional Heterogeneity of Nadph Oxidases in Atherosclerotic and Aneurysmal Diseases.

Authors:  Yasuyoshi Kigawa; Takuro Miyazaki; Xiao-Feng Lei; Joo-Ri Kim-Kaneyama; Akira Miyazaki
Journal:  J Atheroscler Thromb       Date:  2016-07-29       Impact factor: 4.928

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.